File Download

There are no files associated with this item.

Supplementary

Conference Paper: Preliminary results from a phase 2 study evaluating VIR-2218 alone and in combination with pegylated interferon alfa-2a in participants with chronic hepatitis B infection

TitlePreliminary results from a phase 2 study evaluating VIR-2218 alone and in combination with pegylated interferon alfa-2a in participants with chronic hepatitis B infection
Authors
Yuen, RMFLim, Y-SCloutier, DThanawala, VShen, LArizpe, ATay, CGupta, SVCathcart, ALHwang, CGane, E
Issue Date2022
Citation
APASL 2022, Seoul, Korea, 30 Mar - 3 Apr 2022. Hepatology International, v. 16 n. Suppl 1, p. S59 How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/319732

 

DC FieldValueLanguage
dc.contributor.authorYuen, RMF-
dc.contributor.authorLim, Y-S-
dc.contributor.authorCloutier, D-
dc.contributor.authorThanawala, V-
dc.contributor.authorShen, L-
dc.contributor.authorArizpe, A-
dc.contributor.authorTay, C-
dc.contributor.authorGupta, SV-
dc.contributor.authorCathcart, AL-
dc.contributor.authorHwang, C-
dc.contributor.authorGane, E-
dc.date.accessioned2022-10-14T05:18:44Z-
dc.date.available2022-10-14T05:18:44Z-
dc.date.issued2022-
dc.identifier.citationAPASL 2022, Seoul, Korea, 30 Mar - 3 Apr 2022. Hepatology International, v. 16 n. Suppl 1, p. S59-
dc.identifier.urihttp://hdl.handle.net/10722/319732-
dc.languageeng-
dc.relation.ispartofAPASL 2022, Seoul, Korea, 30 Mar - 3 Apr 2022. Hepatology International-
dc.titlePreliminary results from a phase 2 study evaluating VIR-2218 alone and in combination with pegylated interferon alfa-2a in participants with chronic hepatitis B infection-
dc.typeConference_Paper-
dc.identifier.emailYuen, RMF: mfyuen@hku.hk-
dc.identifier.authorityYuen, RMF=rp00479-
dc.identifier.hkuros338991-
dc.identifier.volume16-
dc.identifier.issueSuppl 1-
dc.identifier.spageS59-
dc.identifier.epageS59-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats